search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
118 new news items in the last 24 hours
  1. Home
  2. Health

A drug to treat early-stage Alzheimer's, donanemab, has received a positive opinion from the EMA and is close to authorization in the European Union.

Cristina Petrache
whatsapp
facebook
linkedin
x
copy-link copy-link
27 July 2025, 13:08
main event image
Health
Foto unsplash.com
google-preference

Always see our news on Google

Donanemab, a new drug developed by Eli Lilly for the treatment of early forms of Alzheimer's disease, has received a favorable opinion from the EMA committee, recommending its authorization. The drug, which is intended for patients who are non-carriers or heterozygous for apolipoprotein E ε4, has been shown in clinical trials to slow the progression of cognitive impairment. The drug will be available as an infusible solution, and common side effects include amyloid-associated imaging abnormalities and headache. The final authorization decision rests with the European Commission.

Sources

sursa imagine
Stirile ProTV
Un nou tratament pentru boala Alzheimer în stadii timpurii, aproape de autorizare în UE
sursa imagine
G4Media
Un medicament pentru tratamentul bolii Alzheimer în stadii timpurii, aproape de autorizare în UE
sursa imagine
News.ro
Un medicament pentru tratamentul bolii Alzheimer în stadii timpurii, aproape de autorizare în UE

Latest News

10:24

Washington Post: Trump Adviser Received Hundreds of Thousands of Dollars for Activities Related to Romania

10:14

Iran calls for guarantees for serious negotiations with the US, while Trump says the deal Tehran wants is unacceptable

09:55

Russian attack on the city of Kryvyi Rih: 2 dead, 55 injured

09:36

FBI investigates a possible breach of the national NCIC database, used by police officers for warrants and background checks

09:16

A young man from Neamț was arrested after stealing a taxi and causing an accident

See more news

NEWS ON THE SAME TOPICS

event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
Current Affairs
INSP warns: 12,173 new cases of Alzheimer’s were reported last year in Romania
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
Health
The Minister of Health proposes that treatments for multiple sclerosis also be dispensed through community pharmacies, starting in 2027
event image
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
treatment Alzheimer medically

Editor’s Recommendations

main event image
Exclusive
Yesterday 08:41

EXCLUSIVE | Romania, as viewed by the Russian press / The scenario of unification with the Republic of Moldova, described as a “capitulation” of Chișinău

main event image
Opinions
Yesterday 13:59

Andrei Cornea: Politics, Ethics and Fanaticism

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol